Talis Biomedical Company Insiders

Talis Biomedical Management Team Effectiveness

The company has return on total asset (ROA) of (0.2959) % which means that it has lost $0.2959 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7048) %, meaning that it created substantial loss on money invested by shareholders. Talis Biomedical's management efficiency ratios could be used to measure how well Talis Biomedical manages its routine affairs as well as how well it operates its assets and liabilities. Over half of Talis Biomedical's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Some institutional investors establish a significant position in pink sheets such as Talis Biomedical in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Talis Biomedical, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Talis Biomedical Workforce Comparison

Talis Biomedical Insider Trading

Talis Biomedical Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Talis Biomedical Corp often depends on how effective the management is. Talis Biomedical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Talis management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Talis management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Talis Biomedical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Talis Biomedical Corp. Check Talis Biomedical's Beneish M Score to see the likelihood of Talis Biomedical's management manipulating its earnings.

When running Talis Biomedical's price analysis, check to measure Talis Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Talis Biomedical is operating at the current time. Most of Talis Biomedical's value examination focuses on studying past and present price action to predict the probability of Talis Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Talis Biomedical's price. Additionally, you may evaluate how the addition of Talis Biomedical to your portfolios can decrease your overall portfolio volatility.